Aspirin reduces the risk of hepatocellular carcinoma

This benefit is significant globally, even in patients with cirrhosis or those infected with hepatitis B or C virus.

The results of a comprehensive meta-analysis of 19 clinical trials involving over 2 million individuals suggest that aspirin consumption reduces the risk of hepatocellular carcinoma (HCC) by 30%. The risk reduction was even greater when considering studies conducted in Europe and the United States and less … + read more

Surgical innovation improves outlook for liver cancer

Hepatocarcinoma is the most common liver cancer: 60% to 90% of cases are associated with cirrhosis. +read more

Risk of fatty liver disease increases in summer

Fatty liver or metabolic hepatic steatosis (HeMET) is the most common liver disease in adults, affecting more than 20 percent of the adult population. +read more

Glucose metabolism responds to cooperation between the circadian clocks of muscle and liver.

An international study on the influence of circadian clocks in various tissues suggests that the body has a minimal network needed to control glucose levels. The discovery has clear implications for diabetes and other age-related diseases. +read more

Source link

Leave a Comment